INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M—
7,562 sh
Jan 20, 2026
Page 1687 of 2053
← PrevNext →
Jan 22, 2026
traded Jan 20, 2026
+2d
SEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M—
32.7K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
15.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AK
Ahn KennethPresident, Hagerty Marketplace
HGTYHagerty, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
37.1K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SR
Sinclair III Eric L. (Ric)Chief Business Officer
WAYWaystar Holding Corp.
Option exercise · 10b5-1 plan
M$138K
7,562 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M$53K
13.9K sh
Jan 21, 2026Jan 22, 2026
traded Jan 21, 2026
+1dSEC Form 4

Evidence

0
CL
Chapman Steven LeonardDirector, CEO AND PRESIDENT
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
3,386 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
8,425 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
RD
Rabinowitz DanielSEC. AND CHIEF LEGAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
856 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
3,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
25.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SD
Scimeca DarioGeneral Counsel and Secretary
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
1,978 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
VT
Vanderhook TimothyDirector, CEO and Chairman, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M—
41.3K sh
Jan 22, 2026Jan 22, 2026
traded Jan 22, 2026
+0dSEC Form 4

Evidence

0
BB
Brophy Michael BurkesCHIEF FINANCIAL OFFICER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
1,522 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Sheena JonathanDirector, CO-FOUNDER
NTRANatera, Inc.
Option exercise · 10b5-1 plan
M—
191 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Option exercise · 10b5-1 plan
M—
44.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Option exercise · 10b5-1 plan
M—
13.6K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
10.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
8,335 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
SJ
Smith J. JeffersonChief Research Officer
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
2,500 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
1,000 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
AM
Amoroso MichaelDirector, President and CEO
DTILPRECISION BIOSCIENCES INC
Option exercise · 10b5-1 plan
M—
69.4K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
BD
Brown Sam D.SEVP, Chief Banking Officer
AMALAmalgamated Financial Corp.
Tax withholding · 10b5-1 plan
F$49K
1,524 sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
GK
Goel Rajeev K.Director, CHIEF EXECUTIVE OFFICER, 10% Owner
PUBMPubMatic, Inc.
Derivative conversion · 10b5-1 plan
C—
44.0K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
102.8K sh
Jan 20, 2026Jan 22, 2026
traded Jan 20, 2026
+2dSEC Form 4

Evidence